An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia

by Pandina Gahan, Kushner Stuart, Karcher Keith, Haas Magali
Published 2012-06-01

Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD

by Zhu Young, Bossie Cynthia A, Pandina Gahan J, Gharabawi Georges M
Published 2007-06-01

Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study

by Berry Sally A, Mahmoud Ramy, Brar Jaspreet S, Ganguli Rohan, Pandina Gahan J
Published 2008-06-01

Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study

by Wu Jasmanda, Mahmoud Ramy, Pandina Gahan, Gianfrancesco Frank D, Wang Ruey H
Published 2009-02-01

A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia

by Coppola Danielle, Liu Yanning, Gopal Srihari, Remmerie Bart, Samtani Mahesh N, Hough David W, Nuamah Isaac, Sulaiman Ahmad, Pandina Gahan
Published 2012-03-01